A

ACXEL奥素科技

5 employees

Aosuboxin is a digital microfluidic cell manipulation large area electronic platform to achieve a high degree of integration and automation.

Basic info

Industry

medical equipment manufacturing

Sectors

Consumer Electronics
微流控芯片
Consumer
细胞疗法
生物半导体技术
数字微流控
Electronics
微生物学
化学分析
细胞多组学

Date founded

2020

Funding rounds raised

Total raised

$10M

from 5 investors over 5 rounds

A

ACXEL奥素科技 raised $10M on March 31, 2022

Investors: 深圳市碧桂园创新投资有限公司, Cowin Venture Capital and Qiming Venture Partners

A

ACXEL奥素科技 raised undisclosed on November 16, 2021

Investors: 碧桂园集团 and Cowin Venture Capital

FAQ